1. Home
  2. TECX vs VSTA Comparison

TECX vs VSTA Comparison

Compare TECX & VSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • VSTA
  • Stock Information
  • Founded
  • TECX 2019
  • VSTA 1966
  • Country
  • TECX United States
  • VSTA Brazil
  • Employees
  • TECX N/A
  • VSTA N/A
  • Industry
  • TECX
  • VSTA Other Consumer Services
  • Sector
  • TECX
  • VSTA Real Estate
  • Exchange
  • TECX Nasdaq
  • VSTA Nasdaq
  • Market Cap
  • TECX 387.1M
  • VSTA 397.5M
  • IPO Year
  • TECX 2018
  • VSTA 2020
  • Fundamental
  • Price
  • TECX $18.92
  • VSTA $4.94
  • Analyst Decision
  • TECX Buy
  • VSTA
  • Analyst Count
  • TECX 6
  • VSTA 0
  • Target Price
  • TECX $79.17
  • VSTA N/A
  • AVG Volume (30 Days)
  • TECX 682.4K
  • VSTA 15.7K
  • Earning Date
  • TECX 11-06-2025
  • VSTA 11-06-2025
  • Dividend Yield
  • TECX N/A
  • VSTA N/A
  • EPS Growth
  • TECX N/A
  • VSTA N/A
  • EPS
  • TECX N/A
  • VSTA 1.17
  • Revenue
  • TECX N/A
  • VSTA $326,007,430.00
  • Revenue This Year
  • TECX N/A
  • VSTA $11.22
  • Revenue Next Year
  • TECX N/A
  • VSTA $13.43
  • P/E Ratio
  • TECX N/A
  • VSTA $4.24
  • Revenue Growth
  • TECX N/A
  • VSTA 13.60
  • 52 Week Low
  • TECX $13.70
  • VSTA $1.60
  • 52 Week High
  • TECX $61.07
  • VSTA $5.49
  • Technical
  • Relative Strength Index (RSI)
  • TECX 55.49
  • VSTA 57.17
  • Support Level
  • TECX $18.49
  • VSTA $4.80
  • Resistance Level
  • TECX $20.39
  • VSTA $4.98
  • Average True Range (ATR)
  • TECX 2.22
  • VSTA 0.11
  • MACD
  • TECX 0.14
  • VSTA -0.01
  • Stochastic Oscillator
  • TECX 31.09
  • VSTA 91.47

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

Share on Social Networks: